Mining Data From Plasma Cell Differentiation Identified Novel Genes for Engineering of a Yeast Antibody Factory
Saccharomyces cerevisiae is a common platform for production of therapeutic proteins, but it is not intrinsically suited for the manufacturing of antibodies. Antibodies are naturally produced by plasma cells (PCs) and studies conducted on PC differentiation provide a comprehensive blueprint for the...
Main Authors: | Essi V. Koskela, Alina Gonzalez Salcedo, Mari A. Piirainen, Heidi A. Iivonen, Heidi Salminen, Alexander D. Frey |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fbioe.2020.00255/full |
Similar Items
-
Adaptation of the GoldenBraid modular cloning system and creation of a toolkit for the expression of heterologous proteins in yeast mitochondria
by: Ana Pérez-González, et al.
Published: (2017-11-01) -
Effect of dietary supplementation with yeast cell wall extracts on performance and gut response in broiler chickens
by: A. Pascual, et al.
Published: (2020-05-01) -
Alpha-Terpineol production from an engineered Saccharomyces cerevisiae cell factory
by: Chuanbo Zhang, et al.
Published: (2019-09-01) -
Effect of overexpression of SNF1 on the transcriptional and metabolic landscape of baker’s yeast under freezing stress
by: Lu Meng, et al.
Published: (2021-01-01) -
The structure and function of yeast k1 toxin /
by: Zhu, Hong, 1963-
Published: (1990)